The report offers insights into drivers and restraints of the global clostridium diagnostics market. The increasing prevalence of clostridium related diseases is the key driver for the market. Moreover, the technological developments in diagnostics equipment such as automation and artificial intelligence have given a boost to the growth of the global market. Other factors such as a rising global geriatric population, rapidly growing healthcare infrastructure in emerging economies, and changing lifestyles have triggered the demand for clostridium diagnostics. However, the high cost of these therapies is limiting their uptake, thereby impeding the growth of the market.
Download Exclusive Global Strategic Business Report:
The global clostridium diagnostics market is segmented on the basis of diagnostic tests and emerging diagnostic technologies. Based on diagnostic tests, the market is segmented into counterimmunoelectrophoresis, polymerase chain reactions, and fluorescent-antibody assays. Counterimmunoelectrophoresis is the most widely used diagnostic therapy to detect the nature and functioning of the bacteria. On the basis of emerging diagnostic technologies, the market is segmented into gel microdroplets, chromatography, liposomes, microcomputers and automation, immunoassays, DNA probes, MRI, flow cytometer, artificial intelligence, differential light scattering, monoclonal antibodies, and others. DNA probes are anticipated to emerge as the leading segment owing to their cost effectivity, simplicity, and fast response.
Geographically, North America currently dominates the global clostridium diagnostics market followed by Europe. Prevalence of clostridium and its different species is recorded as being higher in North America and Europe as compared to other regions. Moreover, the high government funding, increased awareness about clostridium related disorders, and the presence of technologically updated systems have fuelled the growth of the clostridium diagnostics market in North America and Europe.
Asia Pacific is expected to expand at a significant CAGR between 2013 and 2019. The growth in this region can be attributed to the improvement in economic conditions and rising awareness about clostridium related diseases and their prevention. Countries such as India and China are estimated to witness noteworthy growth owing to their large population and rapidly growing healthcare infrastructure. The Gulf countries and Brazil are expected to drive the clostridium diagnostics market in the Rest of the World (RoW).
The report gives a detailed description of the competitive landscape of the global clostridium diagnostics market. It includes a profile analysis of key players covering their cost and revenue structures, business strategies, and latest developments. Some of the key players in the market are Abbott Laboratories, Biochem Pharmaceutical Industries Ltd., Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Olympus Corporation, Johnson & Johnson Services, Inc., and Siemens.